Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,146 | -29,400 | -20,288 | -12,117 | -13,460 |
| Depreciation Amortization | 31 | 60 | 36 | 14 | 0 |
| Accounts payable and accrued liabilities | 422 | N/A | 2,758 | 624 | N/A |
| Other Working Capital | 349 | -1,600 | -390 | -3,044 | 1,810 |
| Other Operating Activity | -296 | 340 | -2,597 | -521 | 360 |
| Operating Cash Flow | $-11,640 | $-30,600 | $-20,481 | $-15,044 | $-11,290 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,378 | N/A | -37,268 | -33,785 | N/A |
| PPE Investments | -21 | -810 | -765 | -612 | 0 |
| Other Investing Activity | 0 | -30,770 | 0 | 0 | 0 |
| Investing Cash Flow | $9,357 | $-31,580 | $-38,033 | $-34,397 | $0 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 32,176 | 45,860 | 45,867 | 45,867 | 20,850 |
| Financing Cash Flow | $32,176 | $45,860 | $45,867 | $45,867 | $20,850 |
| Beginning Cash Position | 8,485 | 24,800 | 24,809 | 24,809 | 15,250 |
| End Cash Position | 38,378 | 8,480 | 12,162 | 21,235 | 24,800 |
| Net Cash Flow | $29,893 | $-16,320 | $-12,647 | $-3,574 | $9,550 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,640 | -30,600 | -20,481 | -15,044 | -11,290 |
| Capital Expenditure | -21 | N/A | -765 | -612 | N/A |
| Free Cash Flow | -11,661 | -30,600 | -21,246 | -15,656 | -11,290 |